Congressional Democrats and the White House administration succeeded in passing a law this year that provides sky’s-the-limit funding incentives to clean energy efforts While the law appears to be ensured a long and healthy life,…
Lexaria Bioscience Corp. (NASDAQ: LEXX), a biotechnology company focusing its attention and resources on pursuing the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients, developed the patented DehydraTECH(TM) drug…
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, most recently hosted its Robot Roadshow at Miami Valley Gaming in Lebanon, Ohio, on Oct. 12, 2022. The Robot…
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, is slated to present at this month’s LD Micro Main Event XV…
While a tough economic climate has hurt many businesses in recent years, Golden Matrix has amassed a streak of 16 consecutive profitable quarters The GMGI portfolio includes over 10,000 games and a turnkey system designed…
Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, currently supports over 645 operators and 6.8 million players in its B2B business and over 229,000 players in its…
Three out of four adults living with hypertension do not have the condition under control, putting them at risk for other serious complications Lexaria’s proposed therapy for hypertension is the highly efficient DehydraTECH-CBD, which has…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, announced that it has entered a definitive agreement for the acquisition of CASE Emergency Systems. The transaction is expected to close later this month. According…
Flora Growth Corp. (NASDAQ: FLGC), a global cannabis brand builder, is increasing the strengths of its supply chain, centered in its 100-hectare (about 247-acre) cultivation facility located in the heart of Colombia’s green climate, by…
Aditxt (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced publication of a mathematical model for predicting the durability and rate of…
EverGen renews offtake agreement at Fraser Valley Biogas that covers up to 190,000 gigajoules of RNG annually at more favorable pricing compared to original agreement Offtake marks key milestone that enables full funding of company’s…
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, has named a new chief medical officer. Renowned Stanford cardiologist Peter J.…
Correlate Infrastructure Partners Inc. is a provider of environmentally friendly utilities use optimization solutions, utilizing proprietary data-driven analytics and industry expertise to improve outcomes CIPI recently formed a partnership with Ultra Yield Solutions (“UYS”) to…
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), joined partner The Chopra Foundation in recognizing World Mental Health Day, which was Monday, Oct. 11, 2022. The two organizations are…
Hypertension affects nearly half of all adults in the United States – 47% or 116 million people, some of which are medication-resistant A recent study from the University of Toledo College of Medicine and Life…
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, recently reported financial results for the three- and six-month periods ended June 30, 2022. “Second quarter…
HeartBeam (NASDAQ: BEAT) is a cardiac technology company whose initial focus is on providing diagnostic data through its 3D-vector 12-lead electrocardiogram (“ECG”) platform – the first and only to be developed – for heart attack…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco…
Cannabis grower and product maker Flora Growth is developing its own approach to riding troubling economic forces, boasting a 604 percent YOY increase in the H1 reporting period this year Market analysts predict the global…
Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. The company today announced that it has initiated a preclinical toxicity study of its novel time-released, dosage…